Literature DB >> 30616346

Catalytic Domains of Phosphodiesterase 5, 6, and 5/6 Chimera Display Differential Dynamics and Ligand Dissociation Energy Barriers.

Jason G Pattis1, Shaan Kamal1, Boyang Li1, Eric R May1.   

Abstract

The enzyme phosphodiesterase 6 (PDE6) is a critical component of the visual signaling pathway and functions to convert cGMP to GMP. The ability of PDE6 to affect cellular cGMP levels leads to deactivation of cGMP-gated ion channels in both rod and cone cells. PDE6 has been difficult to structurally characterize experimentally, though the structures of the closely related PDE5 and a PDE5/6 chimera have been determined by X-ray crystallography. In this work, we employ a computational approach to study the dynamics of the catalytic domains of PDE6, PDE5, and the PDE5/6 chimera. Through equilibrium molecular dynamics (MD) simulations, we identify a region of PDE6 (α12) to be correlated to distal regions of the enzyme (H- and M-loops), which surround the catalytic center. These correlations are not observed for PDE5, and we speculate that these unique motions in PDE6 may relate to the high catalytic efficiency of PDE6 and the requirement for an endogenous inhibitory subunit (Pγ). We further investigate the ligand binding pathways and energetics by enhanced sampling simulations (metadynamics) using the inhibitor sildenafil and GMP. The energetics and pathways of ligand binding are consistent with the high efficiency of PDE6 and further implicate the α12 region as an important regulatory element for PDE6 functional dynamics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30616346      PMCID: PMC6502234          DOI: 10.1021/acs.jpcb.8b11370

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  37 in total

1.  Escaping free-energy minima.

Authors:  Alessandro Laio; Michele Parrinello
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

2.  Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations.

Authors:  Alexander D Mackerell; Michael Feig; Charles L Brooks
Journal:  J Comput Chem       Date:  2004-08       Impact factor: 3.376

3.  A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.

Authors:  Kam Y J Zhang; Graeme L Card; Yoshihisa Suzuki; D Richard Artis; Daniel Fong; Sam Gillette; Davin Hsieh; Joshua Neiman; Brian L West; Chao Zhang; Michael V Milburn; Sung-Hou Kim; Joseph Schlessinger; Gideon Bollag
Journal:  Mol Cell       Date:  2004-07-23       Impact factor: 17.970

4.  GROMACS: fast, flexible, and free.

Authors:  David Van Der Spoel; Erik Lindahl; Berk Hess; Gerrit Groenhof; Alan E Mark; Herman J C Berendsen
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

5.  Analysis of PDE6 function using chimeric PDE5/6 catalytic domains.

Authors:  Hakim Muradov; Kimberly K Boyd; Nikolai O Artemyev
Journal:  Vision Res       Date:  2005-10-25       Impact factor: 1.886

6.  Expression of an active, monomeric catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5).

Authors:  T L Fink; S H Francis; A Beasley; K A Grimes; J D Corbin
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

Review 7.  Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction.

Authors:  Alan Laties; Ira Sharlip
Journal:  J Sex Med       Date:  2006-01       Impact factor: 3.802

8.  Phosphodiesterase-5 Gln817 is critical for cGMP, vardenafil, or sildenafil affinity: its orientation impacts cGMP but not cAMP affinity.

Authors:  Roya Zoraghi; Jackie D Corbin; Sharron H Francis
Journal:  J Biol Chem       Date:  2006-01-05       Impact factor: 5.157

Review 9.  Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5.

Authors:  R H Cote
Journal:  Int J Impot Res       Date:  2004-06       Impact factor: 2.896

10.  The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione analogues.

Authors:  Alain Daugan; Pascal Grondin; Cécile Ruault; Anne-Charlotte Le Monnier de Gouville; Hervé Coste; Jean Michel Linget; Jorge Kirilovsky; François Hyafil; Richard Labaudinière
Journal:  J Med Chem       Date:  2003-10-09       Impact factor: 7.446

View more
  2 in total

Review 1.  Photoreceptor phosphodiesterase (PDE6): activation and inactivation mechanisms during visual transduction in rods and cones.

Authors:  Rick H Cote
Journal:  Pflugers Arch       Date:  2021-04-15       Impact factor: 4.458

Review 2.  Photoreceptor Phosphodiesterase (PDE6): Structure, Regulatory Mechanisms, and Implications for Treatment of Retinal Diseases.

Authors:  Rick H Cote; Richa Gupta; Michael J Irwin; Xin Wang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.